STOCK TITAN
  1. Home
  2. News
  3. SEEL

Seelos Therapeutics (SEEL) Stock News, Sep-Dec 2023

SEEL OTC
News

Seelos Therapeutics, Inc. Releases Letter to its Stockholders

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.41%
Tags
none
-
News

Seelos Therapeutics Announces Closing of Public Offering

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
42.03%
Tags
offering
-
News

Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-47.48%
Tags
offering
News

Seelos Therapeutics Announces Proposed Public Offering

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-47.48%
Tags
offering
-
News

Seelos Therapeutics Announces the Selection of SLS-002 (intranasal racemic ketamine) for Inclusion in the U.S. Department of Defense's Adaptive Platform Trial to Evaluate Potential Treatments for Post-Traumatic Stress Disorder (PTSD)

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.79%
Tags
none
-
News

Seelos Therapeutics Announces 1-for-30 Reverse Stock Split

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.95%
Tags
stock split
News

Seelos Therapeutics to Present a Poster on SLS-005 in Alzheimer's Disease at Neuroscience 2023

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.99%
Tags
conferences
-
News

Seelos Therapeutics Retains Canaccord Genuity in Connection with Review of Potential Partnerships and Collaborations

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.33%
Tags
partnership
-
News

Seelos Therapeutics Announces Encouraging Data from an In Vivo Study of SLS-005 in an Aggressive Preclinical Model of Alzheimer's Disease

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.54%
Tags
none
News

Seelos Therapeutics Announces Registered Direct Offering of Common Stock and Warrants to Purchase Common Stock

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-37.73%
Tags
offering

FAQ

What is the current stock price of Seelos Therapeutics (SEEL)?

Seelos Therapeutics (SEEL) last closed at $0.3900.